ClearSign Tech. Prices Public Offering Of 3.64 Mln Shares At $1.11/shr

ClearSign Technologies Corporation (CLIR), a combustion and sensing technologies provider, on Friday announced the pricing of its latest underwritten public offering of 3.64 million shares at $1.11 per share, for gross proceeds of $4.04 million.

With this offering, expected to close on or about June 1, ClearSign aims to use the net proceeds for working capital, research and development, marketing and sales, and general corporate purposes.

The company has also granted the underwriters a 30-day option to purchase an additional 0.546 million shares at $1.11 per share to cover over-allotments in connection with the offering, which if exercised in full would raise the gross proceeds to $4.64 million.

Newbridge Securities Corporation is serving as the sole book-running manager of the offering.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT